Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow

Purpose: to assess the prevalence of primary malignant eyelid tumors and their prognostic features based on the materials of the ocular oncology department, Moscow Ophthalmological Center. Materials and methods. We performed a retrospective analysis of 10-year array (2010–2019) of documents of the M...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Yu. Lerner, O. N. Steshenko
Format: Article
Language:Russian
Published: Real Time Ltd 2022-12-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/1095
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850047516618260480
author M. Yu. Lerner
O. N. Steshenko
author_facet M. Yu. Lerner
O. N. Steshenko
author_sort M. Yu. Lerner
collection DOAJ
description Purpose: to assess the prevalence of primary malignant eyelid tumors and their prognostic features based on the materials of the ocular oncology department, Moscow Ophthalmological Center. Materials and methods. We performed a retrospective analysis of 10-year array (2010–2019) of documents of the Moscow Cancer Register, reports of the ocular oncology department of the Moscow ophthalmological center, S.P. Botkin State Clinical Hospital, and case histories of outpatients with malignant eyelid tumors, residing in Moscow. Results. Malignant ocular tumors were diagnosed in 3650 people. Of these, 75.29 % were eyelid tumors (2748 people). The most common malignant tumor was basal cell carcinoma (89.19 %), which was morphologically diagnosed and over the ten years showed an incidence increase of almost a third. The occurrence rate grows with age, with the peak observed between 70 and 79 years of life. Most often, the lower eyelid (64%) and the inner corner (22.14 %) are affected. Less common are tumors located in the upper eyelid (12.21 %) and at the lateral canthus — 2.3 %. Over 80 % of the relapses occurred at the T2–T3 stages, while only 18.2 % were eyelid skin cancers treated at the T1 stage. Tumors located in the inner corner of the palpebral fissure recurred up to 3 times more often than differently localized eyelid tumors. Conclusion. Malignant eyelid tumors are the most common of malignant ocular neoplasms, claiming ¾ of them. Basal cell carcinoma is the most common type. The peak incidence falls upon the 7th and the 8th decades of life. An increase in the incidence of malignant tumors of the eyelids is observed. The special ophthalmic-oncological service facilitates the diagnostics, treatment and dispensary observation of patients after treatment, which contributes to the early detection of relapses.
format Article
id doaj-art-e2251dbe01e3499e9ef326ca4e424f1a
institution DOAJ
issn 2072-0076
2587-5760
language Russian
publishDate 2022-12-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-e2251dbe01e3499e9ef326ca4e424f1a2025-08-20T02:54:11ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602022-12-01154384410.21516/2072-0076-2022-15-4-38-44519Malignant eyelid tumors: epidemiology and clinical observation of patients in MoscowM. Yu. Lerner0O. N. Steshenko1S.P. Botkin State Clinical Hospital, Moscow Ophthalmological CenterS.P. Botkin State Clinical Hospital, Moscow Ophthalmological CenterPurpose: to assess the prevalence of primary malignant eyelid tumors and their prognostic features based on the materials of the ocular oncology department, Moscow Ophthalmological Center. Materials and methods. We performed a retrospective analysis of 10-year array (2010–2019) of documents of the Moscow Cancer Register, reports of the ocular oncology department of the Moscow ophthalmological center, S.P. Botkin State Clinical Hospital, and case histories of outpatients with malignant eyelid tumors, residing in Moscow. Results. Malignant ocular tumors were diagnosed in 3650 people. Of these, 75.29 % were eyelid tumors (2748 people). The most common malignant tumor was basal cell carcinoma (89.19 %), which was morphologically diagnosed and over the ten years showed an incidence increase of almost a third. The occurrence rate grows with age, with the peak observed between 70 and 79 years of life. Most often, the lower eyelid (64%) and the inner corner (22.14 %) are affected. Less common are tumors located in the upper eyelid (12.21 %) and at the lateral canthus — 2.3 %. Over 80 % of the relapses occurred at the T2–T3 stages, while only 18.2 % were eyelid skin cancers treated at the T1 stage. Tumors located in the inner corner of the palpebral fissure recurred up to 3 times more often than differently localized eyelid tumors. Conclusion. Malignant eyelid tumors are the most common of malignant ocular neoplasms, claiming ¾ of them. Basal cell carcinoma is the most common type. The peak incidence falls upon the 7th and the 8th decades of life. An increase in the incidence of malignant tumors of the eyelids is observed. The special ophthalmic-oncological service facilitates the diagnostics, treatment and dispensary observation of patients after treatment, which contributes to the early detection of relapses.https://roj.igb.ru/jour/article/view/1095malignant eyelid tumorsbasal cell carcinomaeyelid tumors
spellingShingle M. Yu. Lerner
O. N. Steshenko
Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow
Российский офтальмологический журнал
malignant eyelid tumors
basal cell carcinoma
eyelid tumors
title Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow
title_full Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow
title_fullStr Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow
title_full_unstemmed Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow
title_short Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow
title_sort malignant eyelid tumors epidemiology and clinical observation of patients in moscow
topic malignant eyelid tumors
basal cell carcinoma
eyelid tumors
url https://roj.igb.ru/jour/article/view/1095
work_keys_str_mv AT myulerner malignanteyelidtumorsepidemiologyandclinicalobservationofpatientsinmoscow
AT onsteshenko malignanteyelidtumorsepidemiologyandclinicalobservationofpatientsinmoscow